Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Chen Schor currently holds 6,820 shares of EPIX Pharmaceuticals, Inc. (EPIX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Chen Schor has been a net seller of EPIX stock. They have purchased $68.7K and sold $3.8M worth of shares.
Chen Schor's most recent insider trade was on Jan 24, 2026, when they sold 1,755 shares at $8.44 per share.
Chen Schor serves as Executive at EPIX Pharmaceuticals, Inc. (EPIX). They have executed 103 insider transactions totaling $3.9M over their tenure at the company.
Chen Schor holds the position of Executive at EPIX Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Chen Schor has shown a selling trading pattern, with $68.7K in total purchases and $3.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Chen Schor was on Nov 10, 2022, when they sold $601.8K worth of ACET shares. This transaction involved 30,000 shares at $20.06 per share.
Chen Schor currently owns 6,820 shares of EPIX Pharmaceuticals, Inc. (EPIX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Chen Schor's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Chen Schor has 103 Form 4 filings on record as an insider at EPIX Pharmaceuticals, Inc..
Set alerts for Chen Schor and 40,000+ other insiders.